Open access · CC-BY
via OpenAlex
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Shaosen Zhang, Xinyi Xiao, Yonglin Yi, Xinyu Wang, Lingxuan Zhu, Yanrong Shen, Dongxin Lin, Chen Wu
Signal Transduction and Targeted Therapy · 2024 · ▲ 333 citations
Abstract
Tumorigenesis is a multistep process, with oncogenic mutations in a normal cell conferring clonal advantage as the initial event. However, despite pervasive somatic mutations and clonal expansion in normal tissues, their transformation into cancer remains a rare event, indicating the presence of additional driver events for progression to an irreversible, highly heterogeneous, and invasive lesion. Recently, researchers are emphasizing the mechanisms of environmental tumor risk factors and epigenetic alterations that are profoundly influencing early clonal expansion and malignant evolution, independently of inducing mutations. Additionally, clonal evolution in tumorigenesis reflects a multifaceted interplay between cell-intrinsic identities and various cell-extrinsic factors that exert selective pressures to either restrain uncontrolled proliferation or allow specific clones to progress into tumors. However, the mechanisms by which driver events induce both intrinsic cellular competency and remodel environmental stress to facilitate malignant transformation are not fully understood. In this review, we summarize the genetic, epigenetic, and external driver events, and their effects on the co-evolution of the transformed cells and their ecosystem during tumor initiation and early malignant evolution. A deeper understanding of the earliest molecular events holds promise for translational applications, predicting individuals at high-risk of tumor and developing strategies to intercept malignant transformation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41392-024-01848-7
- Canonical
- link ↗
- Fetched
- 2026-06-05 MST
Cite this
APA
Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. (2024). Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets. <em>Signal Transduction and Targeted Therapy</em>. https://doi.org/10.1038/s41392-024-01848-7
Vancouver
Zhang S, Xiao X, Yi Y, Wang X, Zhu L, Shen Y, et al. Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets. Signal Transduction and Targeted Therapy. 2024. doi:10.1038/s41392-024-01848-7.
BibTeX
@article{shaosen2024Tumori,
title = {Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets},
author = {Shaosen Zhang and Xinyi Xiao and Yonglin Yi and Xinyu Wang and Lingxuan Zhu and Yanrong Shen and Dongxin Lin and Chen Wu},
journal = {Signal Transduction and Targeted Therapy},
year = {2024},
doi = {10.1038/s41392-024-01848-7},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Trends in cancer 2020
Open access · CC-BY
Senescent Cells in Cancer Therapy: Friends or Foes?
Cancer Research 2007
Open access · OA
Younger Age of Cancer Initiation Is Associated with Shorter Telomere Length in Li-Fraumeni Syndrome
MedComm 2024
Open access · CC-BY
Cellular senescence in cancer: molecular mechanisms and therapeutic targets
Genes & Cancer 2011
Open access · OA
Li-Fraumeni Syndrome
Genes & Development 2011
Open access · OA
Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state
Carcinogenesis 2009
Open access · OA